Blog Read the latest perspectives from our team of subject matter experts and others FDA Poised to Make Impact on Underrepresented Populations in Clinical StudiesDiversity Action Plans (DAPs) aim to improve data that the FDA receives by increasing the clinical enrollment of historically underrepresented participants. Increasing diversity in clinical trials not only makes the… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Diversity & Inclusion Drug Development Global Impact HCP Volunteers KOL Engagement Provider Data Research Post Industries:Commercialization Global Impact Payors Pharmaceutical & Biotechnology Provider Data Research CommercializationDiversity & InclusionDrug DevelopmentKOL EngagementProvider DataResearchH1 Named to NYC Digital Health 100 by NYCHBLH1, which provides the largest global healthcare platform that connects healthcare professionals, today announced that New York City Health Business Leaders (NYCHBL), the organization that serves as the gateway to… Continue reading → Read the article Diversity & InclusionDrug DevelopmentMaking Clinical Trials More SuccessfulUtilizing all available data sources to optimize clinical trial design and planning, as well as adopting novel trial formats, such as decentralized trials, telehealth and mobile health applications, can get… Continue reading → Read the article CommercializationDiversity & InclusionDrug DevelopmentKOL EngagementProvider DataResearchH1 Wraps Up 2021 with Gratitude2021 was a year of enormous change around the world, as we learn to live and work in new ways. For H1, it was also a year of enormous growth,… Continue reading → Read the article CommercializationDiversity & InclusionDrug DevelopmentKOL EngagementProvider DataResearchCo-Founder and CEO of H1 Named to Forbes 30 Under 30H1 announced today that its CEO and Co-Founder Ariel Katz was named to the prestigious Forbes 30 under 30 list. Ariel started his first company in college, ResearchConnection, to help… Continue reading → Read the article CommercializationDiversity & InclusionDrug DevelopmentKOL EngagementProvider DataResearchZiad Ismail Joins H1 During Period of High GrowthH1, which provides the largest global healthcare network that connects healthcare professionals, announced today that it has added Ziad Ismail to the management team as Chief Operating Officer. Ziad… Continue reading → Read the article CommercializationDiversity & InclusionDrug DevelopmentKOL EngagementProvider DataResearchH1 Raises Series CToday we announced our Series C of $100 million led by Altimeter and participation from new investors including Goldman Sachs Asset Management and Flex Capital. It also includes the support… Continue reading → Read the article«‹891011121314›»